Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : OLEP
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable
Omega 3, Leucine, Probiotic Lactobacillus Paracasei PS23 on Muscle Mass in Sarcopenic Subjects
Details : OLEP is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Sarcopenia.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 08, 2021
Lead Product(s) : OLEP
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Azienda di Servizi alla Persona di Pavia
Deal Size : Inapplicable
Deal Type : Inapplicable